I don't know about the bottom but we should start seeing accumulation. With the revenues actually starting with Pfizers marketing plan going into action and drug stores jumping on board with Nexafed we should start to see a slow and steady rise. This stock is for patient money . Not going to be a home run overnight.
removing other products and pushing Nexafed. No boots on the ground yet as far as sales force on Oxecta but will start in near future
what I was getting at is the court ruling said 50% of the Company received approximately $109.7 million from BARDA under the HHSO10020110001C Contract
siga results: Cash, cash equivalents and short-term investments on December 31, 2013 were $91.3 million, compared to $32.0 million on December 31, 2012. During the year ended December 31, 2013, the Company received approximately $109.7 million from BARDA under the HHSO10020110001C Contract of which approximately $96.1 million was for the aggregate delivery of approximately 725,000 courses of Arestvyr(TM) to the Strategic Stockpile, approximately $5.4 million was for reimbursement of expenses related to research and development expenses and supportive activities, and $8.2 million was for a milestone payment for successfully completing the milestone requirements for the Final Drug Product Commercial Validation batches and report. In addition to the 725,000 courses of Arestvyr delivered to the Strategic Stockpile for which we received payment, 195,000 courses were delivered at no cost to BARDA in accordance with the BARDA Contract.
Looking for good numbers on Nexafed and perhaps a licensing agreement or two...maybe even a rabbit out of that hat...who knows
quickly the news breaks. They present at 4PM Pacific time. Gives us 1 hour of trading and then Wednesday fireworks.
I have heard you beat this drum before. Just short it and make your money if you feel that strongly. Once is enough don't you think?
do know when that happens but its one more adaption for Capstone and their turbines...the dominos are starting to fall
Sentiment: Strong Buy
Heavy-duty trucks spend more time on the road than passenger vehicles, so improving their efficiency can have a major effect on emissions--and their owners' bottom lines.
That's why Walmart is getting into the truck-design business with the WAVE--Walmart Advanced Vehicle Experience--concept.
With its aerodynamic cab, the WAVE certainly doesn't look like any other large truck currently on U.S. roads.
The design was achieved in part by placing the driver in the center of the cab. The steering wheel is flanked by LCD screens--in place of conventional gauges--and there is a sleeping compartment directly behind the driver's pod.
The WAVE features a range-extended electric powertrain, consisting of a Capstone micro-turbine and an electric motor.
To reduce weight, the entire truck is made of carbon fiber--including the trailer.
Walmart says this is the first example of a carbon-fiber trailer ever produced, and that its 53-foot side panels are the first single pieces of carbon fiber that large that have ever manufactured.
Like the tractor, the trailer was also designed for optimum aerodynamic efficiency. It features a convex nose, which not only reduces aerodynamic drag but has the added of benefit of increasing cargo space in the trailer.
It should be interesting to watch Monday considering everyone who may have had a kneejerk reaction and sold, has had time to rethink their emotions and realized they should not have sold...it will probably happen at end of the day once they see where QCOR is headed
SA is in cahoots with them. It drives money to them when they post articles. SA is a full on sham too. It's all about revenues and NOT integrity. When will people realize this???
I don't read SA much...most are in it for click money. They repeat what is already known or just plain love to see there click numbers grow for ego reasons. SA is a platform that is unregulated and I see the motley Fool going the same route. Which is a shame since I really like the Fool.
like a rednecks dog. ITMN suffered for a bit being approved abroad but the street loved the US approval. Here, there is no love...at all. This stock is more like DEPO. It's been a long hard ride just to get to 12 bucks. I think it will be the same here. I have owned DEPO for as long as I can remember and have seen 3 CEO's. Thank God for ITMN and ONXX. They have been my only two homeruns. Hang in there and trade some shares along the way. It beats watching the paint dry which is what I think we have here unless this CEO is willing to sell the company.
Will Booth how the heck are you? Haven't seen ya in some time. Hope all is well.
You can pretty much see it in his photo. This whole wallstreet thing is a sham for crooks and manipulators. Gotta love a guy who's not ashamed to pose and say "Hey look at me, I'm #$%$."
After Equinix reported Q4 results that Pacific Crest views as solid and provided 2014 guidance that the firm thinks is conservative, Pacific Crest thinks the company is benefiting from the shift to the hybrid cloud. The firm believes that the company's pricing is trending positively, and it reiterates a $224 price target and Outperform rating on the shares.
They already did a secondary for the launch of this drug. You must be new here. If there is another offering it will be down the line but I doubt it. A partner will step in soon.
Sentiment: Strong Buy